The company’s new SQF-certified 60,000 square foot manufacturing facility, which offers turnkey gummy formulations, custom flavorings, and bottling solutions for clients.
Captek Softgel International (Cerritos, CA) is officially producing gummy supplements, according to a recent announcement from the company. Gummy production is performed at the company’s new SQF-certified 60,000 square foot manufacturing facility, which offers turnkey gummy formulations, custom flavorings, and bottling solutions for clients. Captek says the new facility can produce 1.5 billion gummies annually in a wide range of shapes, including gummy bears, gumdrops, and cubes. It also has starch-free production lines for for a variety of gummy types, including pectin, agar, carrageenan, gelatin, and combination-based gummies. With its pilot-scale equipment, Captek can produce samples for evaluation with equipment that closely mirrors production, decreasing time to market for seamless scalability.
“We are thrilled to introduce our advanced gummy manufacturing capabilities," said Randy Bridges, chief executive officer at Captek Softgel International, in a press release. "This new facility is expected to substantially increase our capacity and position our organization to manufacture a wider array of products to satisfy changing customer demand.This investment will further position Captek as a leader in contract manufacturing as well as play a significant role in our future growth plans.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.